Last reviewed · How we verify
GNR-055
At a glance
| Generic name | GNR-055 |
|---|---|
| Sponsor | AO GENERIUM |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Multi-cohort Study of Safety, Efficacy, PK and PD of GNR-055 in Patients With Mucopolysaccharidosis Type II (PHASE2, PHASE3)
- A Study of the Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers (PHASE1)
- A Multi-cohort Study of the Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |